Condition · 3 treatment paths
Acute Lymphoblastic Leukemia (ALL)
Acute lymphoblastic leukaemia is a fast-growing cancer in which immature white blood cells multiply in the bone marrow. It is the most common childhood leukaemia but also affects adults.
Send your imaging + plan. Board-reviewed opinion in 5–10 working days.
- Treatment paths
- 3Treatment paths
- Specialties
- 1Specialties
- Typical severity
- SevereTypical severity
About acute lymphoblastic leukemia (all)
What to know
Symptoms include tiredness, pallor, frequent infections, easy bruising and bone pain. Blood counts are abnormal, and diagnosis is confirmed by bone marrow biopsy with genetic testing, which identifies features such as the Philadelphia chromosome and guides risk grouping. Outlook is best in children and is less favourable in older adults and in relapsed disease.
Treatment is intensive multi-phase chemotherapy over about two years, with central nervous system prevention, and targeted drugs for specific subtypes. High-risk or relapsed disease may need allogeneic stem cell transplant, blinatumomab or CAR-T cell therapy. Treatment abroad is considered mostly for relapsed disease, where transplant or CAR-T expertise is needed, and requires close coordination with the home haematologist.
Pre-flight workup
Tests to have already done
- Bone marrow biopsy and flow cytometry reports confirming B-cell or T-cell type and the percentage of blasts.
- Cytogenetic and molecular results, especially the Philadelphia chromosome (BCR-ABL1) and other high-risk changes.
- Minimal residual disease (MRD) results after induction, if available.
- Complete treatment record: chemotherapy protocol, doses, cycles completed and any central nervous system testing.
- HLA typing of the patient and potential related donors if transplant is being considered.
Second opinion
When to get a second look
- The leukaemia has relapsed or MRD remains positive, and you want to understand CAR-T and transplant options.
- Genetic testing was incomplete, particularly for BCR-ABL1, which changes treatment.
- You are an adult or young adult and are being offered a protocol designed for older patients, or the reverse.
- A transplant is proposed in first remission and you want the risks compared with continuing chemotherapy.
Talking to your doctor
Questions to ask
- Which subtype and risk group does my leukaemia fall into, and why?
- What was my MRD result, and how will it guide further treatment?
- Am I a candidate for targeted therapy such as a tyrosine kinase inhibitor?
- When would a transplant or CAR-T therapy be recommended instead of chemotherapy alone?
- What are the effects on fertility, and can it be protected before treatment?
- How will I be monitored for relapse after treatment ends?
Outlook
Realistic prognosis
Outlook varies widely by age and subtype. Most children are cured with modern chemotherapy, and long-term survival is high. In adults, remission is common but cure rates are lower, and relapse is the main concern. Outcomes depend on genetic risk, MRD response, age and fitness. CAR-T therapy and transplant offer a chance of long-term remission for relapsed or high-risk disease.
01 · Specialties
Specialties that treat Acute
Diagnostic workup
Before you pick a hospital, get the workup right
Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.
- Confirm the diagnosis on imaging or labs
For acute lymphoblastic leukemia (all), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
- See a oncology specialist locally first
An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
- Send us the file for a free second opinion
Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
- Pick a path with timeline + cost in writing
Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.
03 · Treatment paths
Treatment options
Where to be treated
Acute Lymphoblastic Leukemia (ALL) treatment by destination
04 · FAQ
Common questions about acute lymphoblastic leukemia (all)
Is ALL curable?
Many children are cured, and a smaller but significant share of adults achieve long-term remission. Outcomes depend on age, genetic features and response to treatment.
How long does treatment last?
Treatment is usually in phases over about two to three years, including maintenance chemotherapy. Transplant or CAR-T therapy are added in higher-risk or relapsed cases.
Can leukaemia come back?
Relapse is possible, most often in the first few years. Regular blood tests and marrow checks look for early signs, and further treatment options exist.
Clinical context
Working up acute lymphoblastic leukemia (all) properly
A condition like acute lymphoblastic leukemia (all) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.
Diagnostic workup, in sequence
- First-line clinical assessment
History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.
- Standard imaging + labs
Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.
- Specialist diagnostic workup
Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.
- Multidisciplinary review (where indicated)
Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.
When to escalate urgently
- Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
- Loss of consciousness, severe persistent vomiting, or any focal neurological event.
- Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
- If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.
Before you book international travel
- Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
- Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
- Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
- Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
- Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Methodology and editorial standards
This acute lymphoblastic leukemia (all) overview is written by the editorial team from published Oncology sources and lists 3 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.
- Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
- Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
- Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
- Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
- Independence. Hospitals cannot pay to change their position on our pages.
Acute Lymphoblastic Leukemia (ALL)
Continue evaluating acute lymphoblastic leukemia (all) care
Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating acute lymphoblastic leukemia (all).
- Surgeons Doctors treating Acute Lymphoblastic Leukemia (ALL) Volume-ranked specialists across all relevant specialties.
- Specialty Oncology hub Programs, surgeons, hospitals across oncology.
- Procedure Chemotherapy (per cycle) First-line treatment with success rates, recovery, hospital pricing.
- Procedure Allogeneic Bone Marrow Transplant Alternative treatment path with cost and recovery data.
- Browse All 79 conditions Map condition → specialty → first-line treatment.
- Browse 9 destination countries Cost-of-care profiles, hospital programs, visa playbooks.
- Compare Hospital comparison Side-by-side accreditations, ratings, beds, and pricing.
- Compare Doctor comparison Surgeons compared on volume, fees, languages, video-consult availability.
- Tool Match-me triage Three questions, get a specialty + destination + 3-hospital shortlist.
- Tool Cost calculator Hospital-reported pricing across procedures × destinations.
- Action Free second opinion Independent panel review of your case in 48 hours — no charge.
Next step · Acute Lymphoblastic Leukemia (ALL)
Free second opinion on your Acute case.
Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.